DNA ploidy and protein content in bronchioloalveolar carcinoma multi-variable flow cytometry

Communications in Clinical Cytometry

Volumn 26, Issue 4, 1996, Pages 253-259

  Huang, Ming S ^a,c   Colby, Thomas V ^a   Therneau, Terry M ^a   Daly, Richard C ^a   Gonchoroff, Nick J ^b  

^a MAYO CLINIC   (United States)

^b SUNY UPSTATE MEDICAL UNIVERSITY   (United States)

^c KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

Author keywords

adenocarcinoma; bronchioloalveolar carcinoma; bronchogenic carcinoma; DNA protein; lung cancer; multi parameter flow cytometry

Indexed keywords

DNA; PROTEIN;

ARTICLE; CONTROLLED STUDY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; LUNG ALVEOLUS CELL CARCINOMA; MAJOR CLINICAL STUDY; PLOIDY; PRIORITY JOURNAL;

ADENOCARCINOMA, BRONCHIOLO-ALVEOLAR; ADULT; AGED; DNA, NEOPLASM; FLOW CYTOMETRY; HUMANS; LUNG NEOPLASMS; PLOIDIES; PROTEINS;

EID: 0030461760     PISSN: 01964763     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0320(19961215)26:4<253::AID-CYTO3>3.0.CO;2-D     Document Type: Article

References (40)

1. American Joint Committee for Cancer Staging and End-Results Reporting, Task Force on Lung:Staging of Lung Cancer, 1979. Chicago:American Joint Committee on Cancer, 1979.
2. Asamura H, Nakajima T, Mukai K, Noguchi M, Shimosato Y:DNA cytofluorometric and nuclear morphometric analyses of lung adenocarcinoma. Cancer 64:1657-1664, 1989.
3. Auer G, Ono J, Caspersson TO:Determination of the fraction of GO cells In cytologic samples by means of simultaneous DNA and nuclear protein analyses. Anal Quant Cytol 5:1-4, 1983.
4. Bauer KD, Merkel DE, Winter JN, Marder RJ, Hauck WW, Wallemark CB, Williams TJ, Variakojis D:Prognostic implications of ploidy and proliferative activity in diffuse large cell lymphomas. Cancer Res 46:3173-3178, 1986.
5. Bunn PA Jr., Carney DN, Gazdar AF, Whang-Peng J, Matthews MJ:Diagnostic and biological implications of flow cytometric DNA content analysis in lung cancer. Cancer Res 43:5026-5032, 1983.
6. Ciancio G, Pollack A, Block NL:Flow cytometric analysis of DNA and nuclear protein in paraffin-embedded tissue. Cytometry 14:205-209, 1993.
7. Cibas ES, Melamed MR, Zaman MB, Kimmel M:The effect of tumor size and tumor cell DNA content on the survival of patients with stage-1 adenocarcinoma of the lung. Cancer 63:1552-1556, 1989.
8. Clayton F:Bronchioloalveolar carcinomas:Cell types, pattern of growth, and prognostic correlates. Cancer 57:1555-1564, 1986.
9. Clayton F:The spectrum and significance of bronchioloalveolar carcinomas. Pathol Annul 23:361-394, 1988
10. Crissman HA, Oka MS, Steinkamp JA:Rapid staining methods for analysis of deoxyribonucleic acid and protein in mammalian cells. J Histochem Cytochem 24:64-71, 1976.
11. Crissman HA, Steinkamp JA:Rapid one-step staining procedures for analysis of cellular DNA and protein by single and dual laser flow cytometry. Cytometry 3:84-90, 1982.
12. Crissman HA, Van Egmond J, Holdrinet RS, Pennings A, Haanen C:Simplified method for DNA and protein staining of human hematopoietic cell samples. Cytometry 2:59-62, 1981.
13. Daly RC, Trastek VF, Pairolero PC, Murtaugh PA, Huang M-S, Allen MS, Colby TV:Bronchoalveolar carcinoma:Factors affecting survival. Ann Thorac Surg 51:368-377, 1991.
14. Darzynkiewicz Z, Sharpless T, Staiano-Coico L, Melamed MR:Sub-compartments of the G1 phase of cell cycle detected by flow cytometry. Proc Natl Acad Sci USA 77:6696-6699, 1980.
15. Engelhard HH III, Krupka JL, Bauer KD Simultaneous quantification of c-myc oncoprotein, total cellular protein, and DNA content using multiparameter flow cytometry. Cytometry 12:68-76, 1991.
16. Ffrench M, Bryon PA, Fiere D, Vu Van H, Gentilhomme O, Adeleine P, Viala JJ:Cell cycle, protein content, and nuclear size in acute myeloid leukemia. Cytometry 6:47-53, 1985.
17. Filderman, AE, Silvestri GA, Gatsonis C, Luthringer DJ, Honig J, Flynn SD:Prognostic significance of tumor proliferative fraction and DNA content in stage I non-small cell lung cancer. Am Rev Respir Dis 146:707-710, 1992.
18. Hedley DW, Friedlander ML, Taylor IW, Rugg CA, Musgrove EA:Method for analysis of cellular DNA content of paraffin embedded pathological material using flow cytometry. J Histochem Cytochem 31:1333-1335, 1983.
19. Herbert DJ, Nishiyama RH, Bagwell CB, Munson ME, Hitchcox SA, Lovett EJ:Effects of several commonly used fixatives on DNA and total nuclear protein analysis by flow cytometry. Am J Clin Pathol 91:535-541, 1989.
20. Hosaka Y, Rainwater LM, Grant CS, Farrow GM, van Heerden JA, Lieber MM:Pheochromocytoma:Nuclear deoxyribonucleic acid patterns studied by flow cytometry. Surgery 100:1003-1008, 1986.
21. Huang M-S, Kato H, Konaka C, Nishimiya K, Yoneyama K, Kawate N, Katsunuma H, Hayato Y:Quantitative cytochemical differences between young and old patients with lung cancer. Chest 88:864-869, 1985.
22. Lea MA:Nuclear proteins of tumors. Int J Biochem 15:767-770, 1983.
23. Manning JT Jr, Spjut HJ, Tschen JA:Bronchioloalveolar carcinoma:The significance of two histopathologic types. Cancer 54:525-534, 1984.
24. Nomori H, Matsuno Y, Noguchi M, Tsugane S, Shimosato Y, Hirohashi S:Adenocarcinoma of the lung with selective metastasis to the lung:Clinical, histologic and DNA-cytofluorometric analyses. Jpn J Cancer Res 83:93-100, 1992.
25. Ojala A, Kallioniemi O-P, Wigren T. Kallioniemi A, Mattila J, Lehtenen M, Koivula T:Flow cytometric analysis of tumor DNA profile related to response to radiotherapy and survival in inoperable lung cancer. Acta Oncologica 29:983-988, 1990.
26. Oud PS, Reubsaet-Veldhuizen JAM, Beck HLM, Pahlplatz MMM, Hesselmans GHFM, Hermkens HG, Tas J, James J and Vooijs GP:DNA and nuclear protein measurement in columnar epithelial cells of human endometrium. Cytometry 7:325-330, 1986.
27. Oud PS, Reubsaet-Veldhuizen JAM, Henderik JBJ, Pahlplatz MMM, Hermkens HG, Tas J, James J, Vooijs GP:DNA and nuclear protein measurement in isolated nuclei of human endometrium. Cytometry 7:318-324, 1986.
28. Piwnicka M, Darzynkiewicz Z, Melamed MR:RNA and DNA content of isolated cell nuclei measured by multiparameter flow cytometry. Cytometry 3:269-275, 1983.
29. Pollack A, Cianciao G, Terry NHA, Block NL:Recognition and reduction of artifacts from autolysis in paraffin-embedded tissue using DNA/nuclear protein flow cytometry. Cytometry 14:565-568, 1993.
30. Pollack A, Moulis H, Block NL, Irvin GL III:Quantitation of cell kinetic responses using simultaneous flow cytometric measurements of DNA and nuclear protein. Cytometry 5:473-481, 1984.
31. Roti Roti JL, Higashikubo R, Blair OC, Uygur N:Cell-cycle position and nuclear protein content. Cytometry 3:91-96, 1982.
32. Stöhr M, Vogt-Schaden M, Knobloch M, Vogel R, Futterman G:Evaluation of eight fluorochrome combinations for simultaneous DNA-protein flow analyses. Stain Technol 53:205-215, 1978.
33. Tanaka I, Masuda R, Furuhata Y, Inoue M, Fujiwara M, Takemura T:Flow cytometric analysis of the DNA content of adenocarcinoma of the lung, especially for patients with stage 1 disease with long term follow-up. Cancer 75:2461-2465, 1995.
34. Teodori L, Trinca ML, Salvati F, Berettoni L, Storniello G, Gohde W:Cellular heterogeneity of DNA/total-protein content in human lung tumors as determined by flow cytometry. Int J Cancer 50:845-853, 1992.
35. Tirindelli-Danesi D, Teodori L, Mauro F, Modini C, Botti C, Cicconetti F, Stipa S:Prognostic significance of flow cytometry in lung cancer:A 5-year study. Cancer 60:844-851, 1987.
36. Tsushima K, Rainwater LM, Goellner JR, van Heerden JA, Lieber MM:Leiomyosarcomas and benign smooth muscle tumors of the stomach:Nuclear DNA patterns studied by flow cytometry. Mayo Clin Proc 62:275-280, 1987.
37. Volm M, Hahn EW, Mattern J, Muller T, Vogt-Moykopf I, Weber E:Five-year follow-up study of independent clinical and flow cytometric prognostic factors for the survival of patients with non-small cell lung carcinoma. Cancer Res 48:2923-2928, 1988.
38. Volm M, Mattern J, Sonka J, Vogt-Schaden M, Wayss K:DNA distribution in non-small-cell lung carcinomas and its relationship to clinical behavior. Cytometry 6:348-356, 1985.
39. Wolley RC, Schreiber K, Koss LG, Karas M, Sherman A:DNA distribution in human colon carcinomas and its relationship to clinical behavior. J Natl Cancer Inst 69:15-22, 1982.
40. Zimmerman PV, Hawson GAT, Bint MH, Parsons PG:Ploidy as a prognostic determinant in surgically treated lung cancer. Lancet 2:530-533, 1987.